Haisco Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Haisco Pharmaceutical Group has a total shareholder equity of CN¥4.2B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 49.4%. Its total assets and total liabilities are CN¥6.9B and CN¥2.7B respectively. Haisco Pharmaceutical Group's EBIT is CN¥380.0M making its interest coverage ratio -3.5. It has cash and short-term investments of CN¥1.3B.
Key information
49.4%
Debt to equity ratio
CN¥2.07b
Debt
| Interest coverage ratio | -3.5x |
| Cash | CN¥1.29b |
| Equity | CN¥4.18b |
| Total liabilities | CN¥2.73b |
| Total assets | CN¥6.91b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002653's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 002653's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥1.3B).
Debt to Equity History and Analysis
Debt Level: 002653's net debt to equity ratio (18.6%) is considered satisfactory.
Reducing Debt: 002653's debt to equity ratio has increased from 47.3% to 49.4% over the past 5 years.
Debt Coverage: 002653's debt is well covered by operating cash flow (24.8%).
Interest Coverage: 002653 earns more interest than it pays, so coverage of interest payments is not a concern.